Patent Assignment
Reel/Frame 008049/0936
Assignment of Assignor's Interest
Recorded: 1996-07-29
Pages: 2
Assignee
UNIVERSITY OF ALBERTA, THE
222 CAMPUS TOWER, 8625-112 STREET, EDMONTON, ALBERTA, T6G 2, CANADA
Covered Property
(1)
Chemokine Binding Protein and Methods of Use Therefor
Patent:
5,834,419 →
Application:
08/634,924 →
Related Assignments
(10)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 20, 1997
From: UNIVERSITY OF ALBERTA, THE
To: JOHN P. ROBARTS INSTITUTE, THE
Reel/Frame 008760/0096 →
Security Interest
Dec 8, 2003
From: VIRON THERAPEUTICS INC.
To: EASTERN TECHNOLOGY SEED INVESTMENT FUND LIMITED PARTNERSHIP; TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG (AS ASSIGNEE OF NOVARTIS INTERNATIONAL AG); ROYAL BANK OF CANADA
Reel/Frame 014754/0290 →
Security Interest
Dec 9, 2003
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
Reel/Frame 014754/0221 →
Security Interest
Dec 9, 2003
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG (AS ASSIGNEE OF NOVARTIS INTERNATIONAL AG); ROYAL BANK OF CANADA; GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
Reel/Frame 014754/0266 →
Security Agreement
Jul 12, 2004
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
Reel/Frame 016256/0117 →
Assignment of Assignor's Interest
Dec 8, 2004
From: JOHN P. ROBARTS RESEARCH INSTITUE, THE
To: VIRON THERAPEUTICS, INC.
Reel/Frame 016046/0558 →
Security Agreement
Jul 8, 2008
From: EASTERN TECHNOLOGY SEED INVESTMENT FUND LIMITED PARTNERSHIP; TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG; ROYAL BANK OF CANADAD
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0109 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0143 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0135 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG; ROYAL BANK OF CANADAD; GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0124 →